New Approaches to HIV and Cancer Cures
April 22, 2019
5:30 pm, Bldg H Conference Room 202/203
Frederick Community College
7932 Opossumtown Pike,
Frederick, MD 21701
American Gene Technologies is a gene and cell therapeutics company with a proprietary lentiviral platform capable of broad applications. AGT expects its patented lead candidate for HIV cure to enter the clinic in 2019, and it has developed a patented immune-oncology approach to attack a variety of epithelial cancers.
CEO, American Gene Technologies